Results with Rituxan
Rituxan® (rituximab) is the only treatment for rheumatoid arthritis (RA) that can provide 6 months of symptom improvement after just 1 course of treatment (2 infusions given about 2 weeks apart).*
In clinical trials, some Rituxan patients experienced symptom improvement just 2 weeks after their first course of treatment. These patients were also treated with methotrexate and methylprednisolone prior to infusion, which may have influenced results at 2 weeks. However, Rituxan patients showed better symptom improvement than non-Rituxan patients at 8 weeks. And for many, that improvement lasted through 6 months.
The benefits of Rituxan can also go beyond 6 months. Studies have shown that if you continue to take Rituxan, it can continue to provide 6 months of that same symptom improvement.
Side effect information: You should know that Rituxan may increase your risk of infection. Tell your healthcare provider if you experience a nagging cough, fever, chills, congestion, or any flu-like symptoms.
*In studies, more than half of the people taking Rituxan experienced a clinically significant improvement in RA signs and symptoms (ACR 20 response). Individual results may vary. Please ask your doctor for more information.
